Matthew H. Kulke
Publications by Year
Research Areas
Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics
Most-Cited Works
- → Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors(2017)3,051 cited
- → PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer(2023)1,721 cited
- → Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study(2015)1,241 cited
- → Carcinoid Tumors(1999)734 cited
- → Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial(2009)649 cited
- → Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors(2008)618 cited
- → Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors(2013)584 cited
- → NANETS Treatment Guidelines(2010)570 cited
- → Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors(2006)516 cited
- → Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer(2017)510 cited